
-
Brain implant turns thoughts into speech in near real-time
-
Top aide to Israel's Netanyahu arrested in 'Qatargate' probe
-
Slashed US funding threatens millions of children: charity chief
-
China property giant Vanke reports annual loss of $6.8 bn
-
World economies brace for Trump tariffs ahead of deadline
-
Myanmar declares week of mourning as quake toll passes 2,000
-
Japan leads hefty global stock market losses on tariff fears
-
Yes, oui, Cannes! Glamour name eyes place in French Cup final
-
'Different energy' at Man Utd after mini-revival, says Amorim
-
Fear of aftershocks in Myanmar forces patients into hospital car park
-
Far-right leaders rally around France's Le Pen after election ban
-
Renault and Nissan shift gears on alliance
-
Hard-hitting drama 'Adolescence' to be shown in UK schools
-
Primark boss resigns after inappropriate behaviour allegation
-
Myanmar declares week of mourning as quake toll passes 2,000, hopes fade for survivors
-
Mbappe can be Real Madrid 'legend' like Ronaldo: Ancelotti
-
Saka 'ready to go' for Arsenal after long injury lay-off: Arteta
-
Aston Martin to sell stake in Formula One team
-
Three talking points ahead of clay-court season
-
French court hands Le Pen five-year election ban
-
Probe accuses ex J-pop star Nakai of sexual assault
-
Japan leads hefty global stock market losses on tariff woes
-
Saka 'ready to go' after long injury lay-off: Arteta
-
Ingebrigtsen Sr, on trial for abusing Olympic champion, says he was 'overly protective'
-
Tourists and locals enjoy 'ephemeral' Tokyo cherry blossoms
-
Khamenei warns of 'strong' response if Iran attacked
-
France fines Apple 150 million euros over privacy feature
-
UK PM urges nations to smash migrant smuggling gangs 'once and for all'
-
Thai authorities probe collapse at quake-hit construction site
-
France's Le Pen convicted in fake jobs trial
-
Chinese tech giant Huawei says profits fell 28% last year
-
Trump says confident of TikTok deal before deadline
-
Myanmar declares week of mourning as hopes fade for quake survivors
-
Japan's Nikkei leads hefty market losses, gold hits record
-
Tears in Taiwan for relatives hit by Myanmar quake
-
Venezuela says US revoked transnational oil, gas company licenses
-
'Devastated': Relatives await news from Bangkok building collapse
-
Arsenal, Tottenham to play pre-season North London derby in Hong Kong
-
Japan's Nikkei leads hefty equity market losses; gold hits record
-
Israel's Netanyahu picks new security chief, defying legal challenge
-
Trump says US tariffs to hit 'all countries'
-
Prayers and tears for Eid in quake-hit Mandalay
-
After flops, movie industry targets fresh start at CinemaCon
-
Tsunoda targets podium finish in Japan after 'unreal' Red Bull move
-
French chefs await new Michelin guide
-
UK imposes travel permit on Europeans from Wednesday
-
At his academy, Romanian legend Hagi shapes future champions
-
Referee's lunch break saved Miami winner Mensik from early exit
-
Djokovic refuses to discuss eye ailment after shock Miami loss
-
Mitchell magic as Cavs bag 60th win, Pistons and T'Wolves brawl
BCC | -0.61% | 97.705 | $ | |
NGG | -0.23% | 65.42 | $ | |
BTI | 1.53% | 41.14 | $ | |
CMSC | 0.08% | 22.48 | $ | |
CMSD | -0.18% | 22.67 | $ | |
GSK | -1.57% | 38.14 | $ | |
RYCEF | -2.16% | 9.7 | $ | |
JRI | 0.57% | 12.944 | $ | |
RIO | -2.78% | 59.38 | $ | |
BCE | 1.25% | 23.26 | $ | |
RBGPF | 1.47% | 68 | $ | |
SCS | 0.85% | 11.195 | $ | |
AZN | -1.42% | 72.755 | $ | |
BP | 0.13% | 33.905 | $ | |
RELX | 0.12% | 50.22 | $ | |
VOD | -0.37% | 9.415 | $ |

Natural immunity more potent than vaccines during US Delta wave: study
During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.
The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).
The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.
Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.
"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.
"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.
The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.
It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.
Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.
- Selection bias? -
By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.
In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.
Protection was highest among those who had both vaccination and prior Covid.
The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.
Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.
But the US CDC had previously taken the opposite position, based on pre-Delta data.
"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.
M.A.Colin--AMWN